Patients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.
Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.
Physicians' and nurses' assessments of the frequency and harm of incidents can be a supplemental method to study patient safety in the primary care office.
Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.
It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.
Improving the appropriate use of colorectal cancer screening requires novel approaches to strike a balance between underuse and overuse.
We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
What can we learn from Biogen's decision to halt sales of aducanumab?
Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.
The authors disagree with previous research concluding that the Home Health Care Consumer Assessment of Healthcare Providers and Services (CAHPS) publicly reported data are insufficiently adjusted for patient comorbidities.
Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.
Significant changes were found in patients' utilization of healthcare related to early implementation of medical home components in VA primary care clinics.
This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.
Healthcare organizations may reduce weight-related health risks and disparities in care among overweight/obese patients through promoting cancer screening exams, healthier diets, and physical activity.
Medicaid managed care network adequacy standards exhibit significant heterogeneity across regions and specialties, potentially creating large variations in health care access and quality.
A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.
Benefits of a patient-centered multimorbidity care management program occurred early, and were evident only among patients with depression and unfavorable medical control of diabetes and heart disease.
Interactive voice response reminders had neither a positive nor a negative effect on promoting influenza vaccination over reminders via postcards, but are a potentially less expensive option.
The use of an 80% threshold or other binary cut point may be insufficient for characterizing the relationship between medication adherence and Medicare spending.